These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8089899)

  • 21. Thrombocytopenia in association with adjunctive felbamate use.
    Ney GC; Schaul N; Loughlin J; Rai K; Chandra V
    Neurology; 1994 May; 44(5):980-1. PubMed ID: 8190314
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic drug monitoring of felbamate].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involuntary movement disorders associated with felbamate.
    Kerrick JM; Kelley BJ; Maister BH; Graves NM; Leppik IE
    Neurology; 1995 Jan; 45(1):185-7. PubMed ID: 7824115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment: warfarin-felbamate interaction.
    Glue P; Banfield CR; Colucci RD; Perhach JL
    Ann Pharmacother; 1994 Dec; 28(12):1412-3. PubMed ID: 7696739
    [No Abstract]   [Full Text] [Related]  

  • 25. Warfarin-felbamate interaction: first report.
    Tisdel KA; Israel DS; Kolb KW
    Ann Pharmacother; 1994 Jun; 28(6):805. PubMed ID: 7919574
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychiatric effects of felbamate.
    Ketter TA; Malow BA; Post RM; Theodore WH
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):118-9. PubMed ID: 9017538
    [No Abstract]   [Full Text] [Related]  

  • 27. Secondary mania associated with the use of felbamate.
    Hill RR; Stagno SJ; Tesar GE
    Psychosomatics; 1995; 36(4):404-6. PubMed ID: 7652143
    [No Abstract]   [Full Text] [Related]  

  • 28. Criteria for use of felbamate in adult, adolescent, and child inpatients and outpatients.
    Luer MS
    Am J Hosp Pharm; 1994 Jul; 51(13):1701-3; Quiz 1704-5. PubMed ID: 7942896
    [No Abstract]   [Full Text] [Related]  

  • 29. Status epilepticus induced by Felbatol withdrawal.
    DeGiorgio CM; Lopez JE; Lekht ZN; Rabinowicz AL
    Neurology; 1995 May; 45(5):1021-2. PubMed ID: 7746379
    [No Abstract]   [Full Text] [Related]  

  • 30. Felbamate-induced headache.
    Ettinger AB; Jandorf L; Berdia A; Andriola MR; Krupp LB; Weisbrot DM
    Epilepsia; 1996 May; 37(5):503-5. PubMed ID: 8617182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin.
    Devinsky O; Vazquez B; Luciano D
    J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1993 Oct; 270(14):1672. PubMed ID: 8411485
    [No Abstract]   [Full Text] [Related]  

  • 33. Felbamate: new preparation. May benefit multiresistant epileptic patients.
    Prescrire Int; 1998 Jun; 7(35):78-81. PubMed ID: 10342924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Felbamate: perspectives for new antiepileptic treatment].
    Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M
    Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Felbamate.
    Med Lett Drugs Ther; 1993 Nov; 35(910):107-9. PubMed ID: 8232064
    [No Abstract]   [Full Text] [Related]  

  • 36. Felbamate-induced delayed anaphylaxis.
    O'Neil MG; Probst L; Patel S
    Ann Pharmacother; 1995 Apr; 29(4):430. PubMed ID: 7633024
    [No Abstract]   [Full Text] [Related]  

  • 37. Felbamate in epilepsy therapy: evaluating the risks.
    Pellock JM
    Drug Saf; 1999 Sep; 21(3):225-39. PubMed ID: 10487399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric side effects related to treatment with felbamate.
    McConnell H; Snyder PJ; Duffy JD; Weilburg J; Valeriano J; Brillman J; Cress K; Cavalier J
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):341-6. PubMed ID: 8854308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new anticonvulsant drugs. Implications for avoidance of adverse effects.
    Schmidt D; Krämer G
    Drug Saf; 1994 Dec; 11(6):422-31. PubMed ID: 7727052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose pharmacokinetics of felbamate in patients with renal dysfunction.
    Glue P; Sulowicz W; Colucci R; Banfield C; Pai S; Lin C; Affrime MB
    Br J Clin Pharmacol; 1997 Jul; 44(1):91-3. PubMed ID: 9241102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.